For an 88-year-old resident with recent cold-like symptoms, a negative respiratory polymerase chain reaction panel for severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and influenza A/B, a normal chest radiograph, and a normal white blood cell count, should the exposure be considered COVID‑19 or influenza, and is repeat viral testing, empiric antiviral therapy, or supportive care recommended?

Recommendation for 88-Year-Old with Negative Respiratory Panel

Continue supportive care and monitoring without repeat testing or empiric antiviral treatment, given the negative respiratory PCR panel, normal chest X-ray, and normal WBC count. 1

Rationale for No Repeat Testing

The 2024 IDSA COVID-19 diagnostic guidelines explicitly suggest against routine repeat testing in symptomatic individuals with an initial negative NAAT result 1. The yield of repeat testing is low, and routine repetition is not recommended. Repeat testing should only be considered in specific situations:

• Development of new or worsening symptoms without alternative explanation
• Concern for poorly collected specimen
• If performed, repeat testing should occur 24-48 hours after initial testing 1

In this case, the patient has stable cold symptoms without progression, making repeat testing unnecessary.

Why Not Empiric Antiviral Treatment?

For COVID-19:

The IDSA guidelines recognize "the lack of evidence supporting therapy for asymptomatic persons and the absence of treatment approved for asymptomatic COVID-19" 1. While this patient is symptomatic, the negative PCR panel makes empiric COVID-19 treatment inappropriate without confirmed diagnosis.

For Influenza:

The 2009 IDSA LTCF guidelines recommend diagnostic confirmation during outbreaks 2. With a negative influenza PCR, empiric treatment is not indicated, especially given:

• Normal vital signs (implied by stable presentation)
• No pneumonia on chest X-ray
• Normal WBC count (6.1)

Addressing the Exposure Question

You cannot definitively determine whether the exposure was COVID-19 or influenza based on clinical presentation alone. Research shows overlapping symptoms between these infections 3, 4, though some patterns exist:

• COVID-19 patients tend to have fewer respiratory symptoms (less cough, sputum, fatigue) 3
• Influenza patients more commonly present with sore throat, cough, muscle aches, and higher fever 4
• Laboratory differences exist (COVID-19: higher NLR 5; Influenza: higher WBC, more pronounced symptoms 3)

However, with a normal WBC of 6.1, this patient doesn't fit the typical influenza pattern of elevated WBC 4.

Clinical Monitoring Plan

Continue supportive care with monitoring for:

1. Worsening respiratory symptoms (increased dyspnea, hypoxia)
2. New fever or fever recurrence
3. Development of pneumonia symptoms (productive cough, pleuritic pain)
4. Functional decline beyond baseline

Important Caveats

False-Negative Testing

While false-negative PCR results can occur 6, 7, they are uncommon with modern multiplex panels. The combination of:

• Negative comprehensive respiratory panel
• Normal chest X-ray
• Normal WBC count
• Stable clinical course

Makes a missed serious viral infection highly unlikely.

When to Reconsider Testing

Repeat testing would be warranted if 1:

• Symptoms worsen significantly
• New respiratory symptoms develop
• Clinical deterioration occurs
• Chest X-ray changes develop

Age Consideration

At 88 years old, this patient is high-risk for complications. However, the current clinical stability (normal vital signs implied, normal labs, clear chest X-ray) does not justify empiric treatment without confirmed diagnosis. Close monitoring is more appropriate than empiric therapy given the negative testing.

The exposure source remains indeterminate without testing the source patient, but this does not change management given the negative comprehensive respiratory panel and stable clinical presentation.